Key result
Guanethidine plasma levels ≥8 ng/ml predict adrenergic blockade despite high interindividual dose variation.
Why the study?
The relationship between plasma guanethidine levels and adrenergic blockade in hypertensive patients was not well characterized.
Does guanethidine plasma concentration correlate with adrenergic blockade in hypertensive patients?
Observational (n=17)
Does guanethidine plasma concentration correlate with adrenergic blockade in hypertensive patients?
Adrenergic blockade by guanethidine occurs at plasma levels of 8 ng/ml or higher, suggesting that large interindividual variations in dose requirements are driven by pharmacokinetics rather than differing plasma level requirements.
Answers are grounded in this paper and cite their sources.
Plasma monitoring may address guanethidine dose variation in hypertension; leaves open whether it improves outcomes in prospective trials.
Seventeen hypertensive patients receiving guanethidine for therapy were studied to determine the relationship of guanethidine plasma levels to adrenergic blockade. Plasma levels of guanethidine were measured by gas chromatography-mass spectrometry, and adrenergic blockade was defined by determining the venous reflex response to Valsalva maneuver or deep breath. A significant correlation was found between the change in the venous reflex response and the fall in mean standing pressure when guanethidine is given to patients maintained on a sodium restricted diet. A linear relationship was found between dose and plasma guanethidine concentration (p less than 0.0001), but there was a 6-fold interindividual variation in the plasma levels resulting from any given dose. Adrenergic blockade occurred when plasma levels were 8 ng/ml or higher. These results indicate that the large individual variation in dose requirements for the hypotensive effects of guanethidine most likely is not due to requirements for greatly different plasma levels of the drug; that the variation must result from pharmacokinetic determinants of differing plasma levels between individuals or from other factors, such as increased plasma volume, which maintain elevated arterial pressure in the face of adrenergic blockade.
No takes yet. Share an insight, caveat, or question.
Walter et al. (1975) conducted an observational in Hypertension (n=17). Guanethidine plasma levels was evaluated on Adrenergic blockade (venous reflex response to Valsalva maneuver or deep breath) (p=<0.0001). Guanethidine plasma levels ≥8 ng/ml achieved adrenergic blockade, with a linear relationship between dose and plasma concentration despite a 6-fold interindividual variation.
Synapse has enriched 10 related papers. Consider them for comparative context: